- Presentations
- 5
- Markets
- 1
Jakafi is a brand of Ruxolitinib marketed by Incyte, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ruxolitinib
- Brand owner
- Incyte
- Registered in
- United States
- Strengths and forms
- 10 mg tablet, 15 mg tablet, 20 mg tablet, 25 mg tablet, 5 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Jakafi 10 mg tabletOral | Incyte | US FDA | Available on request |
| Jakafi 15 mg tabletOral | Incyte | US FDA | Available on request |
| Jakafi 20 mg tabletOral | Incyte | US FDA | Available on request |
| Jakafi 25 mg tabletOral | Incyte | US FDA | Available on request |
| Jakafi 5 mg tabletOral | Incyte | US FDA | Available on request |
Equivalent brands
Other brands of Ruxolitinib.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Jakafi
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.